Biocircuits files for thyroid test clearance
This article was originally published in Clinica
Executive Summary
Biocircuits has submitted a 510(k) marketing clearance application to the US FDA for its thyroid stimulating hormone assay. The test is designed for use with the US company's IOS point-of-care immunodiagnostic system, which was launched in the US in March this year.